LUMOSA THERAPEUTICS CO.,LTD 4F NO 3.2. PARK ST NANGANG DIST TAIPEI CITY 115603 TAIWAN

LUMOSA THERAPEUTICS CO.,LTD

Company Introduction:

LUMOSA THERAPEUTICS CO.,LTD is a biopharmaceutical company based in Taiwan, dedicated to the research, development, and commercialization of novel drugs for unmet medical needs. The company focuses on developing innovative therapies, particularly in areas such as acute ischemic stroke, neuropathic pain, and oncology. Lumosa Therapeutics conducts extensive R&D, manages clinical trials, and aims to bring new pharmaceutical products to market to improve patient outcomes globally.

Business Type:

LUMOSA THERAPEUTICS CO.,LTD is a **pharmaceutical company** engaged in drug research, development, and commercialization. It is neither a traditional factory (though it may oversee manufacturing processes or partner with contract manufacturers) nor a trading company. Its core business is the innovation and development of new medicines.

LUMOSA THERAPEUTICS CO.,LTD

Products:

LT1001: A long-acting opioid analgesic for postoperative pain relief. This product is approved and marketed in Taiwan.

LT3001: A novel small molecule drug for acute ischemic stroke, designed with neuroprotective, thrombolytic, and antithrombotic mechanisms. It is currently in Phase 3 clinical trials.

LT2001: A long-acting local anesthetic for pain management. This product is currently in preclinical development.

LT002: A therapeutic candidate for Alzheimer's Disease. This product is currently in preclinical development.

LT003: A therapeutic candidate for Diabetic Retinopathy. This product is currently in preclinical development.